Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Athens"

3 News Found

Unimed to expand operations into Singapore with Marine Pharma merger
News | June 06, 2023

Unimed to expand operations into Singapore with Marine Pharma merger

Establishes distribution center in top hub for international shipping

New nirsevimab data analyses reinforce efficacy against RSV
Biotech | May 11, 2022

New nirsevimab data analyses reinforce efficacy against RSV

Nirsevimab is the first investigational immunization designed to protect all infants across the RSV season with a single dose

BiologyWorks k(now) handheld molecular device 99.1 % accurate to RT-PCR test
Medical Device | January 18, 2022

BiologyWorks k(now) handheld molecular device 99.1 % accurate to RT-PCR test

Results from the BiologyWorks k(now) molecular test were 99.1% in overall percent agreement with the results of the RT-PCR lab tests

Latest Stories

AstraZeneca's Saphnelo succeeds in Phase III as self-injectable lupus treatment

Novo Nordisk’s Wegovy delivered 16.6% weight loss

Bayer inaugurates new phytomedicines lab facility

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries

Packaging